Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone versus triamcinolone injection for carpal tunnel syndrome
IRCT20210920052535N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of medical ozonated water, triamcinolone and lidocaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Boston Questionnaire symptom severity and functional status, Visual Analog Scale symptom severity and 3 more. Started May 2021; status: completed.
02
Drugs
medical ozonated watertriamcinolonelidocaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20210920052535N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210920052535N1.